Hansraj College

University of Delhi

NAAC Grade A+ with CGPA 3.62

Dr Brijesh Rathi

Assistant Professor | Department of Chemistry
Contact (Off.): +91-11-27667458

Email Address : brijeshrathi[at]hrc[dot]du[dot]ac[dot]in
URL : http://hansrajcollege.ac.in/vfp.php?id=28
View Resume

Organic Chemistry, Medicinal Chemistry and Drug Dicovery

  • PhD , 2010 , University of Delhi
  • M.Sc. , 2003 , CCS University, Meerut
  • B.Sc. , 2001 , CCS University, Meerut
  • Affiliate/Adjunct Assistant Professor [October 1, 2018 – September 30, 2021], Department of Medicine, Stritch School o Medicine, University of Loyola, Chicago, United States of America.
  • Affiliate/Adjunct Professor [September 1, 2019 – August 30, 2022], Department of Pharmaceutical Chemistry, University of Debrecen, Hungary.
  • Visiting Assistant Professor [August 1, 2016 - July 31, 2017], Department of Chemistry, Massachusetts Institute of Technology (M.I.T.), 77 Massachusetts Avenue, Cambridge, MA 02139 United States of America
  • Visiting Professor - CAPES Fellow (15-30 November 2019), UFRPE, Recife, Brazil. 
  • Assistant Professor [Dec 15, 2014-Till], Department of Chemistry, Hansraj College University Enclave, University of Delhi, Delhi-110007.
  • Assistant Professor [Aug 5, 2010-Dec 14, 2014], Department of Chemistry, Sri Venkateswara College, University of Delhi, New Delhi-110021.
  • Visiting Fellow [June 6-16, 2016], Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Moscow, Russia.
  • Visiting Fellow [June 30 –July 7, 2016], Belarussian State University, Minsk, Belarus. Visiting Fellow [Oct. 2014], Centro de Química da Madeira, Universidade da Madeira, Campus da Penteada, 9020-105 Funchal, Portugal.
  • Principal Investigator [2011-2014], Department of Chemistry, University of Delhi, Delhi-110007 Title of the Project: “Novel functionalized tetrahedral activated small peptidomimetic inhibitors of malarial aspartic proteases, plasmepsin I and plasmepsin II” Funding Agency: Department of Science and Technology, Ministry of Science and Technology, Government of India.

Organic Chemistry, Chemistry of Biomolecules, Environmental Chemistry

  • Dr. Pramila Gupta (Doctoral Degree Awarded 2021)
  • Neha Sharma (Ph.D student): 2018- 
  • Prem P Sharma (Ph.D student): 2018- 
  • Meenakshi Bansal (Ph.D student): 2019-
  • Ayushee (PhD Student): 2018-
  • Meghna Agrawal (Project Fellow): 2021- 
  • Deepshikha Gururani (Project Fellow): 2019-
  • Sonu Kumar (Project Fellow): 2019-2020
  • Snigdha Singh (Project Fellow): 2016-2018. 
  • Atul Kumar (Master Thesis): 2019.
  • Convener of College Research Committee, 2018.
  • Convenor, Research Committee, Hansraj College, University of Delhi (2018 onwards).
  • Convenor, Institutional Innovation Cell (IIC), A Unit of MHRD-Innovation Cell, Hansraj College, University of Delhi (2018-).
  • Coordinator, Centre for Global Health Study Site, a unit of Global Health Center Loyola Universit University Chicago, USA.
  • Coordinator, Laboratory For Translational Chemistry and Drug Discovery, Hansraj College, University of Delhi.
  • Member of Hostel Committee, 2015-16

Synthesis, Conformational Features and Reactivity Studies of Sym N,N’,N”-Triarylguanidines (2010)

Title of the project: “Repurposing of Drugs and Validation of Lead Compounds Against Main Protease and RNA Dependent RNA Polymerase of SARS-CoV-2”
Funding Agency: DST, Government of India
Duration: Three Years (2021-2023)
Project Cost: 42.87 Lakh
Role: Co-PI

Title of the project: “Design and Synthesis of Novel Bioactive DOTA Conjugates”
Funding Agency: INMAS-DRDO, Government of India
Duration: Three Years (2021-2022)
Project Cost: 8.90 Lakh
Role: PI

Title of the Project: “Lead Optimization of Potent Multistage Antimalarials”
Funding Agency: SERB, Government of India
Duration: Three Years(2020-2023)
Project Cost: 46.41 Lakh
Role: PI 

Title of the Project: 'Development of Nanoantenna Sensor for Infrared Detection"
Funding Agency: DST, Ministry of Science and Technology, Government of India
Duration: Two Years(2019-2021)
Project Cost: 63.08 Lakh
Role: PI

Title of the Project: "Design and Catalytic Large-Scale Synthesis of New Functionalized Perfluorinated Ketones/Ethers as Potential Fire Extinguishants"
Funding Agency: DRDO, Ministry of Defence, Government of India
Project Cost: 48.2 Lakh
Duration: Three Years 

Role: PI
Title of the Project: “A New Class of Anti-malarials: Constituting New Avenues for Anti- malarialTherapy”
Funding Agency: SERB, Government of India
Duration: Three Years (2016-2019)
Project Cost: 32.89 Lakh Role: PI 

Title of the Project: “Novel functionalized tetrahedral activated small peptidomimetic inhibitors of malarial aspartic proteases, plasmepsin I and II”
Funding Agency: Department of Science and Technology, Ministry of Science and Technology, Government of India
Project Cost: 10 Lakh
Duration: Three Years (2011-2014)
Role: PI

Title of the project: “Contributions to bio-informatics…….against infectious diseases” (INT/BLR/P-4/2014)
Funding Agency: Department of Science and Technology, Ministry of Science and Technology, Government of India
Project cost: 5 Lakh
Duration: Two years (2014-2015) Role: Co-PI

Title    of     the    project: “Functionalized     nano-antimalarials….…….plasmepsin     II”
Funding Agency: Department of Science and Technology, Ministry of Science and Technology, Government of India
Project cost: 5 Lakh
Duration: Three years (2014-2017)
Role: Co-PI

Title of the Project: “Thio-click approach for the synthesis of stable glycomimetics and chiral oxathiacrown ethers”
Funding Agency: Department of Science and Technology, Ministry of Science and Technology, Government of India
Project Cost: Indo-Hungarian Bilateral Research Grant Duration: Three Years (2017-2020)
Role: Co-PI

Title of the Project: “Conjugates and Analogues of Antiviral Compound AUY11 (INT/RUS/RFBR/P-194/2015)”
Funding Agency: Department of Science and Technology, Ministry of Science and Technology, Government of India
Project Cost: 24.28 Lakh (Indo-Russian Bilateral Research Grant)
Duration: Two Years (2015-2017)
Role: Co-PI (In collaboration with IIT Delhi)

Title of the Project: “Survey of Tree Species in Delhi Region and Screening of Selected Medicinal Plants for Anti-Cancer Activity” (SVC-101)
Funding Agency: University of Delhi Project Cost: 10 Lakh
Duration: One Year (2012-2013).

Title of the Project: “Engineered Biocompatible Organic Nanoarchitectures: A New Paradigm for Disinfections” (HRC-308)
Funding Agency: University of Delhi Project Cost: 6 Lakh
Duration: One Year (2015-2016.

  • Kumar S., Kumari P., Rathee G., Rathi B. (2021) Nanomaterials for Early Cancer Diagnostics. In: Malik A., Afaq S., Tarique M. (eds) Nanomedicine for Cancer Diagnosis and Therapy. Springer, Singapore. p.p. 97-114. https://doi.org/10.1007/978-981-15-7564-8_5
  • Brijesh Rathi and Poonam (2018) “Chemical Therapeutics for the treatment of alcoholism” ALCOHOLISM: Causes, Symptoms Effects and Treatment. Page: 237-248 Manakin Press, New Delhi India (ISBN: 9789-38667-7488).
  • Renuka, N.; Babu, R.; Vijayan, N.; Rathi, B.; Thukral, K. "Effect of Oxygen Ion Irradiation on the Structural and Optical Properties of L-Arginine Acetate Single Crystals" Recent Trends in Material Science and Application 2017, 511-519 (Springer, ISBN: 978-3-319- 44890-9).
  1. Sharma, N.; Kashif, M.; Singh, V.; Fontinha, D.; Mukherjee, B.; Kumar, D.; Singh, S.; Prudêncio, M.; Singh, A.*; Rathi, B.* “Novel antiplasmodial compounds leveraged with multistage potency against Parasite Plasmodium falciparum: In vitro, in vivo evaluations and pharmacokinetic studies” J. Med. Chem. 2021, 64, 8666–8683 (IF, 7.44; American Chemical Society; ISSN, 1520-4804).
  2. Gupta, Y.; Kumar, S.; Zak, S.; Jones, K.; Upadhyay, C.; Sharma, N.; Azizi, S-A.; Kathayat, R.; Poonam; Herbert, A.; Durvasula, R.; Dickinson, B.; Dye, J.; Rathi , B.*; Kempaiah, P.* “Antiviral Evaluation of Hydroxyethylamine Analogs: Inhibitors of SARS-CoV-2 Main Protease (3CLpro), A Virtual Screening and Simulation ApproachBioorg. Med. Chem. 2021 Accepted10.1016/j.bmc.2021.116393 (IF: 3.641; Elsevier; ISSN: 0968-0896).
  3. Kumar, S.; Gupta, Y.; Zak, S.; Jones, K.; Upadhyay, C.; Sharma, N.; Herberty, A.; Durvasula, R.; Potemkin, V.; Dye, J.; Poonam; Kempaiah, P.*; Rathi , B.*; “A novel compound active against SARS-CoV-2 targeting Uridylate-specific endoribonuclease (NendoU/NSP15): In silico and in vitroinvestigations” RSC Med. Chem. 2021 Accepted DOI: 10.1039/D1MD00202C (Royal Society of Chemistry UK; ISSN, 2632-8682).
  4. Bansal, M.; Upadhyaya, C.; Poona; Kumar, S.; Rathi, B.* ‘Phthalimide Analogs for Antimalarial Drug Discovery’ RSC Med. Chem. 2021 DOI: 10.1039/D1MD00244A Accepted, August (Royal Society of Chemistry UK; ISSN, 2632-8682).
  5. Oliveira, V.N.; Moura, C.; Peixoto, A.; Ferreira, VPS.; Araújo, H.M.; Pimentel, L.M.L.; Pessoa, C.;Nicolete, R.; Anjos, J.; Sharma, P. P.; Rathi, B.; Pena, L.; Rollin, P.; Tatibouët, A.; Oliveira, R.“Synthesis of alkynylated 1,2,4-oxadiazole/1,2,3-1H-triazole glycoconjugates: discovering new drug candidates for use in chemotherapy against lung carcinoma and Mycobacterium tuberculosisEur J. Med. Chem. 2021, 220, 113472 (IF: 6.514; Elsevier, Netharlands; ISSN, 0223-5234).
  6. Rolta, R.; Salaria, D.; Sharma, P. P.; Sharma, B.; Kumar, V.; Rathi, B.; Verma, M.; Sourirajan, A.; Baumler, D. A.; Dev, K. “Phytocompounds of Rheum emodi, Thymus serpyllum, and Artemisia annua Inhibit Spike Protein of SARS-CoV-2 Binding to ACE2 Receptor: In Silico Approach” Curr. Pharmacol.Rep. 2021 Accepted https://doi.org/10.1007/s40495-021-00259-4 (IF, 1.52; Springer International Publishing Switzerland; ISSN, 2198641X).
  7. Maurya, S.; Nayar, K.; Jha, N.; Jha, S.; Kesari, K.; Roychoudhury, S.; Sharma, A.; Kumar, A.; Rathi, B.; Kumar, D. “Metabolic dysregulation and sperm motility in male infertility” Adv. Exp. Med. Biol. 2021Accepted July (IF, 2.4; Springer Nature; ISSN, 2214-8019).
  8. Chandel,V.; Kumar, A.; Kumar, A.; Rathi, B.; Kumar, D. Role of Monocarboxylate Transporters in Head and Neck Squamous Cell Carcinoma. Life Sci. 2021, 279, 119709 (IF, 5.037; Elsevier; ISSN, 0024-3205).
  9. Chandel, V.; Tripathi, G.; Nayar, S. A.; Rathi, B.; Kumar, A.; Kumar, D. “In silico identification and validation of triarylchromones as potential inhibitor against main protease of severe acute respiratory syndrome coronavirus 2” J. Biomol. Struct. Dyn. 2021 Accepted https://doi.org/10.1080/07391102.2021.1918255 (IF,3.78; Elsevier; ISSN, 1095-9130).
  10. Feng, D.; Wei, F.; Sun, Y.; Sharma, P.; Zhang, T.; Lin, H.; Rathi, B.; Clercq, E.; Pannecouque, C.; Kang, D.; Zhan, P.; Liu, X. “Boronic acid-containing diarylpyrimidine derivatives as novel HIV-1 NNRTIs: design, synthesis, and biological evaluation” Chin. Chem. Lett. Accepted 2021https://doi.org/10.1016/j.cclet.2021.02.033 (IF, 6.779; Elsevier; ISSN 1001-8417).
  11. Raj, S.; Mathur, A.; Rathi, B.; Kumar, N.; Jha, S. K.; Kumar, D. “Mutational Heterogeneity in Spike Glycoproteins of Severe Acute Respiratory Syndrome Coronavirus 2” 3 Biotech 2021, 11236 (IF, 1.798; Springer; ISSN, 2190-5738).
  12. Arfin, S.; Jha, N. K.; Jha, S. K.; Kesari, K.;  Ruokolianen, J.; Roychoudhury, S.;  Rathi, B.; Kumar, D. “Oxidative Stress in Cancer Cell MetabolismAntioxidants 2021, 10, 642 (IF, 6.312; MDPI Switzerland; ISSN: 2076-3921).
  13. Gupta Y.; Maciorowski, D.; Zak, S.; Jones, K.; Kathayat, R.; Azizi, S.; Mathur, R.; Pearce, C.; Ilc, J.; Husein, H.; Herbert, A.; Bharti, A.; Rathi, B.; Durvasula, R.; Becker, D.; Dickinson, B.; Dye, J.; Kempaiah, P. “Bisindolylmaleimide IX: A novel anti-SARS-CoV2 agent targeting viral main protease 3CLpro demonstrated by virtual screening pipeline and in-vitro validation assays” Methods 2021Accepted https://doi.org/10.1016/j.ymeth.2021.01.003 (IF, 3.608; Elsevier; ISSN, 1095-9130).
  14. Gupta, Y.; Goicoechea, S.; Pearce, C.; Mathur, R.; Romero, J.; Kwofie, S.; Weyenberg, M.; Daravath, B.; Sharma, N.; Poonam, Akala, H.; Kanzok, S.; Durvasula, R.; Rathi, B.; Kempaiah, P. “The emerging paradigm of calcium homeostasis as a new therapeutic target for Protozoan Parasites” Med. Res. Rev.2021 In Press https://doi.org/10.1002/med.21804 (IF, 12.994; Wiley-VCH Verlag GmbH & Co. KGaA, Germany; ISSN: 1098-1128).
  15. Kumar, S.; Upadhyaya, C.; Kempaiah, P.; Rathi, B.; Poonam “Multi-targeting approach for nsp3, nsp9, nsp12 and nsp15 proteins of SARS-CoV-2 by Diosmin as illustrated by Molecular Docking and Molecular Dynamics simulation methodologies” Methods 2021 Accepted https://doi.org/10.1016/j.ymeth.2021.02.017 (IF, 3.608; Elsevier; ISSN, 1095-9130).
  16. Sharma, P.; Kumar, S.; Srivastava, S.; Srivastava, M.; Jee, B.; Gorobets, N.; Kumar, D.; Kumar, M.;Asthana, S.; Zhang, P.; Poonam, Zoltner, M.; Rathi, B.* “Computational validation of novel inhibitory molecule, 1-(4-((2S,3S)-3-amino-2-hydroxy-4-phenylbutyl)piperazin-1-yl)-3-phenylurea, with high potential to competitively block ATP binding to the RNA dependent RNA polymerase of SARS-CoV-2 virus" J. Biomol. Struct. Dyn. 2021 Accepted https://doi.org/10.1080/07391102.2021.1940281 (IF, 3.310/2018; Taylor & Francis; ISSN, 1538-0254).
  17. Chandel, V.; Sharma, P. P.; Kumar, N.; Jha, N.; Rathi, B.; Kumar, D. “In silico identification of potential inhibitor for TP53-induced glycolysis and apoptosis regulator in head and neck squamous cell carcinoma” 3Biotech 2021, 11, 117  https://doi.org/10.1007/s13205-021-02665-3 (IF, 2.406; Springer; ISSN, 2190-5738).
  18.  Sharma, P.; Kumar, S; Kumar K.; Singh, A.; Singh, I.; Grishina, M.; Pandey, K.; Singh, P.; Potemkin, V.; Poonam, Singh, G.; Rathi, B. “In silico Validation of Novel Inhibitors of Malarial Aspartyl Protease, Plasmepsin V and Antimalarial Efficacy Prediction” J. Biomol. Struct. Dyn. 2021 Accepted https://doi.org/10.1080/07391102.2021.1911855 (IF, 3.3549; Taylor & Francis; ISSN, 1538-0254).

2020

  1. Sharma, N.; Gupta, Y.; Bansal, M.; Singh, S.; Pathak, P.; Shahbaaz, M.; Mathur, R.; Singh, J.; Kashif, M.; Grishina, M.; Potemkin, V.; Rajendran, V.; Poonam; Kempaiah, P.; Singh, A.; Rathi, B.* “Multistage Antiplasmodial Activity of Hydroxyethylamine Compounds, In vitro and In vivo Evaluations” RSC Adv. 2020, 10, 35516-35530 (IF: 3.361; Royal Society of Chemistry, UK; ISSN: 2046-2069).
  2. Raj, S.; Chandel, V.; Rathi, B. and Kumar, D. Understanding the Molecular Mechanism(s) of SARS-CoV2 Infection and Propagation in Human to Discover Potential Preventive and TherapeuticApproach”, Coronaviruses, 2020,1, 73-81.  
  3. Srivastava, S.; Verma, S.; Kamthania, S.; Agarwal, D.;Saxena, A.; Kolbe, M.; Rathi, B.;Nayar, A.; Shin, H.; Vashisht, K.; Pandey, K. C. “Computationally validated SARS-CoV-2 CTL and HTL Multi-Patch Vaccines designed by reverse epitomics approach, shows potential to cover large ethnically distributed human population worldwide” J. Biomol. Struct. Dyn. 2020 Accepted (IF, 3.310/2018; Taylor & Francis; ISSN, 1538-0254).
  4.  Chandel, V.; Sharma, P. P.; Raj, S.; Choudhari, R.; Rathi, B.; Kumar, D. “Structure-based drug repurposing for targeting Nsp9 replicase and spike proteins of severe acute respiratory syndrome coronavirus 2” J. Biomol. Struct. Dyn. 2020 In Press DOI: 10.1080/07391102.2020.1811773 (IF, 3.310/2018; Taylor & Francis; ISSN, 1538-0254).
  5.  Kumar, S.; Goicoechea, S.; Kumar, S.; Pearce, C. M.; Durvasula, R.; Kempaiah, P.; Rathi, B.*; Poonam* “Oseltamivir analogs with potent anti-influenza virus activity” Drug Discov. Today. 2020, 25, 1389-1402 (IF, 7.851; Elsevier Netherland; ISSN, 1359-6446).
  6. Kumar, S.; Sharma, P. P.; Shankar, U.; Kumar, D.; Joshi, S. K.; Pena, L.; Durvasula, R.; Kumar, A.; Kempaiah, P.; Poonam; Rathi, B.* “Discovery of New Hydroxyethylamine Analogs Against 3CLpro Protein Target of SARS-CoV-2: Molecular Docking, Molecular Dynamics Simulation and Structure-Activity Relationship Studies” J. Chem. Inf. Model. 2020 60, 12, 5754 (IF, 4.956; American Chemical Society; ISSN, 1549-9596).
  7. Kumar, S.; Upadhyay, C.; Bansal, M.; Grishina, M.; Potemkin, V.; Rathi, B.*; Poonam* “Experimental and computational studies of microwave assisted, facile ring opening of epoxide with less reactive aromatic amines in nitromethane” ACS Omega 2020, 5, 30, 18746–18757 (IF, 3.512; American Chemical Society; ISSN, 2470-1343).
  8. Kumar, S.; Poonam, Rathi, B. “Coronavirus Disease COVID-19: A New Threat to Public HealthCurr. Topics Med. Chem. 2020 Accepted doi: 10.2174/1568026620999200305144319 (IF: 3.442; Bentham Science Publishers, UAE; ISSN, 1568-0266).
  9. Chhikara, BS.; Rathi, B.; Singh, J.; Poonam “Corona virus SARS-CoV-2 disease COVID-19: Infection, prevention and clinical advances of the prospective chemical drug therapeutics” Chem. Biol. Lett. 2020, 7, 63-72 (Scopus Indexed; ISSN, 2347-9825).
  10. Singh, S.; El-Sakkary, N.; Skinner, D. E.; Sharma, P. P.; Ottilie, S.; Antonova-Koch, Y.; Kumar, P.; Winzeler, E.; Poonam; Caffrey, C. R.*; and Rathi, B.* “Synthesis and bioactivity of phthalimide analogs as potential drugs to treat schistosomiasis, a neglected disease of poverty” Pharmaceuticals, 2020, 13, 25 (IF, 5. 863; MDPI Switzerland; ISSN, 1424-8247).
  11. Upadhyay, C.; Monika; Oliveira, R.; Borbas, A.; Kempaiah, P.; Poonam; Rathi, B.* “Fluorinated scaffolds for antimalarial drug discovery” Expert Opin Drug Dis 2020 Accepted DOI: 10.1080/17460441.2020.1740203 (IF, 6.098; Taylor & Francis UK; ISSN, 1746-045X).
  12. Kelemen, V.; Csávás, M.; Péter, M.; Herczeg, M.; Poonam, Rathi, B.; Jain, N.; Borbás, A. “Photoinitiated Thiol-Ene Reactions of Various 2,3-Unsaturated O-, C- S- and N- Glycosides - Scope and Limitations Study” Chem. Asian J. 10.1002/asia.201901560 (IF, 4.568; Wiley-VCH Verlag GmbH & Co. KGaA, Germany; ISSN, 1861-471X).
  13. Zhang, S.; Xiao, M.; Zhang, Y.; Li, Y.; Liu, H.; Han, G.; Rathi, B.; Wu, L.; “Mimicking Neuromelanin Nanoparticles As a Selective Pb2+ Probe” Analytica Chim. Acta. 2020 Accepted (IF, 6.558; Elsevier Netharlands; ISSN, 1873-4324).
  14. Kwofie, S.; Emmanuel, B.; Dankwa, B.; Enninful, K.; Teye, J.; Davidson, C.; Nimely, J.; Rathi, B.; Miller, W. “Review of Atypical Organometallic Compounds As Antimalarial Drugs” J. Chem. 2020 In press (IF, 1.727; Hindawi Publishers London, ISSN, 2090-9071).
  15. Kwofie, SK; Broni,……Rathi, B.; Miller, W. A.; Yaya, A.; Wilson, M. D. “Outwitting an Old Neglected Nemesis: A Review on Leveraging Integrated Data-Driven Approaches to Aid in Unraveling of Leishmanicides of Therapeutic Potential” Curr. Topics Med. Chem. 2020 Accepted (IF: 3.295; Bentham Science Publishers, UAE; ISSN, 1568-0266).

2019

  1.  Singh, S.; Achieng, A. O.; Vandana: Pant, A.; Nasamu, A. S.; Pandit, M.; Singh, J.; Quadri, A.; Gupta, N.; Poonam; Ghosh, P. C.; Singh, B. K.; Latha, N.; Kempaiah, P.; Chandra, R.; Dunn, B. M.; Pandey, K. C.; Goldberg, D. E.; Singh, A.*; and Rathi, B.* “Fast-acting small molecules targeting malarial aspartyl proteases, plasmepsins, inhibit malaria infection at multiple life stages”. ACS Infect. Dis. 2019, 5, 184-198 (IF: 5.084; American Chemical Society; ISSN, 2373-8227).
  2.  Chistov, A. A.; Orlov, A. A.; Streshnev, P. P.; Slesarchuk, N. A.; Aparin, I.O.; Rathi, B.; Brylev, V. A.; Kutyakov, S. V.; Mikhura, I. V.; Ustinov, A. V.; Westman, G.; Palyulin, V.A.; Jain, N.; Osolodkin, D.I.; Kozlovskaya, L. I.; Korshun, V. A. Compounds based on 5- (perylen-3-ylethynyl)uracil scaffold: high activity against tick-borne encephalitis virus and non-specific activity against enterovirus A.” Eur. J.Med. Chem. 2019, 171, 93-103 (IF: 6.514; Elsevier, Netharlands; ISSN, 0223-5234).
  3. Wu, L.; Xu, Z.; Meng, Q.; Xiao, Y.; Cao, Q.; Rathi, B.; Liu, H.; Han, G.; Zhang, J.; Yan, J. “A New Aptamer/Black Phosphorous Interdigital Electrode for Malachite Green Detection” Analytica Chim. Acta. 2020, 1099, 39-45 (IF: 6.558; Elsevier Netharlands; ISSN, 1873- 4324).
  4. Poonam, Kumari, P.; Grishina, M.; Potemkin, V.; Verma, A.; Rathi, B. Oxygen mediated highly efficient cobalt(II) porphyrin-catalyzed reduction of functional chromones: Experimental and Computational studies. New J. Chem., 2019 2019, 43, 5228-5238 (IF: 3.591; Royal Society of Chemistry).
  5. Kumar, S.; Wu, L.; Sharma, N.; Ayushee; Kaushik, K.; Grishina, M.; Chhikara, BS.; Poonam; Potemkin, V.; Rathi, B.* “Theoretical and experimental studies of an oseltamivir–triazole-based thermoresponsive organogel” RSC Adv., 2019, 9, 21031 (IF: 3.361; Royal Society of Chemistry, UK; ISSN: 2046-2069).
  6. Chhikara, B.S.; Rathi, B.; Keykavous, P. “Critical Evaluation of Pharmaceutical Rational Design of Nano-Delivery Systems for Doxorubicin in Cancer Therapy. J. Mat. NanoSci. 2019, 6, 47-66 (Indian Science Publishers; ISSN: 2394-0867).
  7. Sharma, N., Verma, A.; Poonam, Kempaiah, P., and Rathi, B.* “Chemical libraries targeting Liver Stage Malarial infection. Chem. Biol. Lett., 2019, 6, 14-22 (Scopus Indexed; ISSN, 2347-9825).
  8. Kotnala, K.; Verma, K.; Sharma, A.; Parashar, S.; Rathi, B.; Kumar, R.; Chhikara, B. S.; Singh, J.Indian Medicinal Plants for skin care and cosmeceuticals: A review” J. Biomed. Ther. Sci. 2019, 6(2), 2460 (Indian Science Pub.; ISSN: 2394-2274).

2018

  1. Poonam; Gupta, Y.; Singh, S.; Wu, L.; Rawat, M. and Rathi, B.* “Multistage Inhibitors of Malaria Parasite: Emerging Hope for Chemoprotection and Malaria Eradication” Med. Res. Rev. 2018, 38, 1511-1535 (IF, 12.99; Wiley-VCH Verlag GmbH & Co. KGaA, Germany; ISSN: 1098-1128).
  2. Singh, S.; Sharma, N.; Upadhyay, C.; Kumar, S.; Rathi, B.; Poonam “Small Molecules Effective against Liver and Blood Stage Malarial Infection” Curr. Topics Med. Chem. 2018, 18, 2008-202 (IF: 3.295; Bentham Science Publishers, UAE; ISSN: 1568-0266).
  3. Wu, L.; Rathi, B.; Chen, Y.; Wu, X.; Liu, H.; Li, J.; Ming, A.; Han, G.; “Characterization of immobilized Tyrosinase--an enzyme that is stable in organic solvent at 100 oC” RSC Adv. 2018, 8, 39529-39535 (IF: 3.361; Royal Society of Chemistry, UK; ISSN: 2046-2069).
  4. Singh, S.; Singh, A.; Rathi, B.; Tomar, V.; Chandra, R. “Modern Advancement in the Area of Antimalarial Drug Development” Indian J. Heterocyclic Chem. 2018, 28, 185-194.
  5. Singh, A. K.; Rajendran, V.; Singh, S.; Kumar, P.; Kumar, Y.; Singh, A.; Miller, W.; Potemkin, V. Poonam; Grishina, M.; Gupta, N.; Kempaiah, P.; Durvasula, R., Singh, B.; Dunn, B. M. and Rathi, B.* “Antiplasmodial activity of hydroxyethylamine analogs: Synthesis, biological activity and structure activity relationship of plasmepsin inhibitors” Bioorg. Med. Chem. 2018, 26, 3837-3844 (IF: 3.641; Elsevier; ISSN: 0968-0896).
  6. Miller, W. A.; Teye, J.; Achieng, A.O.; Mogire, R. M.; Akala, H.; Ong’cha, J. M.; Rathi, B.; Durvasula, R.; Kempaiah, P.; Kwofie, S. K. “Antimalarials: Review of Plasmepsins as Drug Targets and HIV Protease Inhibitors Interactions”. Curr. Topics Med. Chem. 2018, 18, 2022-2028. (IF: 3.295; Bentham Science Publishers, UAE; ISSN: 1568-0266).
  7. Kumari, V.; Singh, A.  P.; Singh J.; Sharma, R.; Akhter, M.; Mishra, P.  K.; Saxena, A. K.; Dixit, R.; Rathi, B.; Katyal, A. and Pandey, K. C. “Biochemical Characterization of 2017 Unusual Cysteine Protease of P. falciparum, Metacaspase-2 (MCA-2)” Mol. Biochem. Parasitol. 2018, 220, 28-41 (IF: 2.536; Elsevier; ISSN: 0166-6851).

2017/2016

  1. Kumar, P.; Achieng, A. O.; Rajendran, V.; Ghosh, P.; Singh, B.K.; Rawat, M.; Perkins, Douglas J.; Kempaiah,P.; Rathi, B.* "Synergistic blending of high-valued heterocycles inhibits growth of Plasmodium falciparum in culture and P. berghei infection in mouse model" Sci. Rep. 2017, 7, 6724 (IF, 4.379; Nature Group Publications, Netherland; ISSN: 2045-2322).
  2. Gorobets, N.; Yuriy S.; Singh B.; Poonam and Rathi, B.* “An Overview of Currently Available Antimalarials” Curr. Topics Med. Chem. 2017, 17, 2143-2157 (IF: 3.295; Bentham Science Publishers, UAE; ISSN: 1568-0266).
  3. Editorial: Rathi, B.; Yaroslav, F.; Latha, N.; Poonam “New Avenues in Controlling Infectious Diseases” Curr. Topics Med. Chem. 2017, 17, 2113 (IF: 3.295; Bentham Science Publishers, UAE; ISSN: 1568-0266).
  4. Singh, A.; Bhardwaj, J.; Olival, A.; Kumar, Y.; Podder, A.; Maheshwari, A.; Latha, N.; Singh, B. K.; Tomás, H.; Rodrigues, J.; Rathi, B.* “Design, Synthesis and Biological Evaluation of Arylpiperazine Based Novel Phthalimides: Active Inducers of Testicular Germ Cell Apoptosis” J. Chem. Sci. 2016, 128, 1245-1263 (IF: 1.254; Springer; ISSN: 0973- 7103).
  5. Meet Our Editorial Board Member, Curr. Topics Med. Chem., 2016, 16, 895-896 (IF: 2.9; ISSN: 1568-0266).
  6. Singh, A.; Medviediev, V. V.; Shishkin, O.; Bahadur, V.; Singh, T.; Singh, B. K.; Vijayan, N.; Balachandran, V.; Gorobets, Yu N. and Rathi, B.* “Functionalized Organic Frameworks Explored As Second Order NLO Agents” J. Chem. Sci. 2016, 128, 297-309 (IF: 1.254; Springer; ISSN: 0973-7103).
  7. Gupta, N.; Gupta, C.; Sharma, S.; Rathi, B.; Sharma, R. K. and Bohidar, H. B. “Magnetic iron oxide nanoparticles encapsulating horseradish peroxidase (HRP): synthesis, characterization and carrier for the generation of free radicals for potential applications in cancer therapy” RSC Adv. 2016, 6, 111099 (IF: 3.361; Royal Society of Chemistry, UK; ISSN: 2046-2069).
  8. Chhikara, B. S., Kumar, R., Rathi, B., Krishnamoorthy, S., & Kumar, A. “Prospects of Applied Nanomedicine: potential clinical and (bio)medical interventions via nanoscale research advances” Chem. Biol. Lett. 2016, 3, 50-56 (Scopus Indexed; ISSN, 2347-9825).

2015

  1. Singh, A. K.; Rathore, S.; Tang, Y.; Goldfarb, N. E.; Dunn, B. M.; Rajendran, V.; Ghosh, P. C.; Latha, N.; Singh, B. K. and Rathi, B.* Hydroxyethylamine Based Phthalimides As New Class of Plasmepsin Hits: Design, Synthesis and Antimalarial Evaluation” Plos ONE 2015, 10, e0139347 [IF: 3.24; Plos; ISSN: eISSN-1932-6203].
  2. Singh, A. K.; Rajendran, V.; Ghosh, P. C.; Singh, N.; Latha, N.; Garg, S.; Pandey, K. C.; Singh, B. K.; Rathi, B.* “Design, Synthesis and Biological Evaluation of Functionalized Phthalimides: A New Class of Antimalarials and Inhibitors of Falcipain-2, a Major Hemoglobinase of Malaria Parasite” Bioorg. Med. Chem. 2015, 23, 1817–1827 (IF: 3.641; Elsevier; ISSN: 0968-0896).
  3. Editorial: Rodrigues, J. and Rathi, B. “Self-assembled Organic Nanostructures in Medicinal Chemistry: Advances and Applications” Curr. Topics Med. Chem. 2015, 15, 1161-1161 (IF: 2.90; ISSN: 1568-0266).
  4. Sharma, P.; Rathi, B.; Rodrigues, J.; Gorobets, Yu. N. “Self-Assembled Peptide Nanoarchitectures: Applications and Future Aspects” Curr. Topics Med. Chem. 2015, 15, 1268-1289 (IF: 3.40; ISSN:1568-0266).
  5. Sharma, A.; Sharma, S.; Sharma, K.; Chetri, S.; Vashishtha, A.; Singh, P.; Kumar, R.; Rathi, B; and Agarwal, V. “Algae as crucial organisms in advancing nanotechnology: a systematic review” J. Appl. Phycol. 2015, 28, 1759-1774 (IF: 3.215; Citation: 1; Springer, ISSN: 1573-5176).

2014

 

  1. Rani, R.; Thukral, K.; Krishna, A.; Vijayan, N. Rathi, B. “Synthesis and nucleation studies on L-leucine hydrobromide: a promising nonlinear optical material” J. Appl. Crystallogr. 2014, 47, 1966-1974 (IF: 3.95; ISSN: 1600-5767).
  2. Singh, A.; Balachandran, V.; Vijayan, N.; Bahadur, V.; Tiwari, H.; Singh, B. and Rathi, B.* “Synthesis, Structural Aspects and Nonlinear Optical Properties of Novel Phthalimide Derivatives: Theoretical and Experimental Approach” J. Phys. Org. Chem. 2014, 27, 490- 497 (IF: 1.229; John Wiley & Sons; ISSN: 1099-1395).
  3. Krishna, A.; Thukral, K.; Vijayan, N.; Riscob, B.; Haldhar, S.; Rathi, B.; Jacob, P. “Synthesis and single crystal growth of L-proline cadmium chloride monohydrate and its characterization for higher order harmonic generation applications” CrystEngComm, 2014, 16, 2802-2809 (IF: 3.545; Citation: 8; Royal Society of Chemistry, UK; ISSN: 1466- 8033).
  4. Vijayan, V.; Philip, J.; Haranath, V.; Rathi, B.; Bhagavannarayana, G.; Halder, S.; Roy, N.; Jayalakshmy, M. S. and Verma, S. “Bulk growth of ninhydrin single crystals by solvent evaporation method and its characterization for SHG and THG applications” Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy 2014, 122, 309- 314 (IF: 4.098; Elsevier; ISSN: 1386-1425).
  5. Sharma, P. P.; Kumar, R.; Singh, A.; Singh, B. K.; Kumar, A and Rathi B.* “Potentials of Hydrogels in Cancer Therapy” Curr. Cancer Ther. Rev. 2014, 10, 246-270 (Bentham Science Publications; Citation: 1; ISSN: 1875-6301).
  6. Rathi, B.; Sharma, P.; Singh, R. P. “Tetrahedral Hydroxyethylamine: A Privileged Scaffold in Development of Antimalarial Agents” Chem. Biol. Lett. 2014, 1, 11-13 (Indian Science Publications; ISSN: 2347–9825).

2013

  1. Rathi, B.*; Singh, A.; Kishan, R.; Latha, N.; Pandey, K. C. Tiwari, H. and Singh, B. K. ‘Functionalized hydroxyethylamine based peptide nanostructures as potential inhibitors of falcipain-3, an essential proteases of Plasmodium falciparum’ Bioorg. Med. Chem. 2013, 21, 5503–5509 (IF: 3.441; Elsevier; ISSN: 0968-0896).
  2. Singh, A.; Kishan, R.; Vijayan, N.; Balachandran, V.; Tiwari, H.; Singh, B. and Rathi, B.* “Entry of Chiral Phthalimides With Significant Second Order Nonlinear Optical and Piezoelectric Properties’ RSC Adv., 2013, 3, 14750-14756 (IF: 3.589; Royal Society of Chemistry, UK; ISSN: 2046-2069).
  3. Kishan, R.; Vijayan, N.; Rupini, B.; Singh, R.; Kumar, Y. and Rathi, B.* “Structural Aspects, Biological and Nonlinear Optical Response of New N,Nʹ–Di(2- tolyl)formamidinium Tosylate” Adv. Chem. Lett. 2013, 1, 134-139 (American Scientific Publishers, USA; ISSN: 2326-7488).
  4. Rupini, B.; Sharda, P.; Rathi, B.* “Asymmetric Reductive Amination of Carbonyl Compounds by Using N,N,N-Tributylpropanaminium Based Novel Chiral Ionic Liquid” Int. J. Org. Chem., 2013, 3, 190-193. (IF: 0.57; Scientific Research Publishers, USA; ISSN: 2161-4695).
  5. Rani, N.; Vijayan, N.; Riscob, B.; Jat, S. K.; Das, S.; Bhagwannarayan, G.; Rathi, B.; Wahab, M. A. “Single Crystal Growth of Ninhydrin by Unidirectional Sankaranarayanan- Ramasamy (SR) Method by Using Glass Ampoule For Non-linear Optical Applications” CrystEngComm, 2013, 15, 2127–2132 (IF: 4.069 for five years; Royal Society of Chemistry, UK; ISSN: 1466-8033).
  6. Vijayan, N.; Rani, N.; Madhurambal, G.; Bhagavannarayana, G.; Rathi, B.; Philip, R.; Safakath, K.; Mojumdar, S. C. ‘Synthesis, growth, and characterization of iminodiacetic acid monohydrochloride’ J. Thernal Analysis and Calorimetry 2013, 112, 1113-1119; (IF: 1.604; Springer; ISSN: 1572-8943).
  7. Vijayan, N.; Bhagwannarayan, G.; Halder, S. K.; Verma, S.; Philip, J.; Rathi, B. “X-ray Topography, Photopyroelectric and Two-photon Absorption Studies on Solution Grown Benzimidazole Single Crystal” Appl. Phys. A 2013, 110, 55-58 (IF: 1.630; Springer; ISSN: 1432-0630).
  8. Aggarwal, A.; Kumari, R.; Mehla, N.; Deepali, Bhatnagar, S.; Sharma, K.; Sharma, V.; Rathi, B.*“Depletion of the Ozone Layer and Its Consequences: A Review” Am. J. Plant Sci., 2013, 4, 1990-1997 (IF: 0.27; Scientific Research Publishers, USA; ISSN: 2158-2750).

2012

  1. Rani, N.; Vijayan, N.; Rathi, B.; Bhagavannarayana, G. “Studies on the effect of polymer coating on solution grown hygroscopic non-linear optical single crystal of L-lysine monohydrochloride”Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy 2012. 97, 871-875 (IF: 4.098; Elsevier; ISSN: 1386-1425).
  2. Vijayan, N.; Bhagavannarayana, G.; Maurya, K. K.; Haranath, D.; Rathi, B.; Balamurgan, N.; Sharma, Y. K.; Ramasamy, P. “Effect of Annealing on Bridgman Grown Organic Scintillation Material of trans-Stilbene” MatChemPhys 2012, 132, 453-457. (IF: 2.234; Elsevier; ISSN: 0254-0584).
  3. Renuka, N.; Vijayan, N.; Rathi, B.; Nagarajan, K.; Ramesh Babu, R.; Bhagavannarayana, G. “Synthesis, Growth and Optical Properties of Semi Organic Non-linear Optical Single Crystal: L-Arginine Acetate” OPTIK 2012, 123, 189-192. (IF: 0.510; Elsevier; ISSN: 0030- 4026).

2010

  1. Gopi, K.; Rathi, B.; Natesan, T. “Synthesis and Conformational Features of N,N',N"-Triarylguanidines”J. Chem. Sci. 2010, 122, 157-167.
  2. Mahapatra, S. C.; Tiwari, H. K.; Singla, M.; Rathi, B.; Sharma, A.; Mahiya, K.; Kumar, M.; Sinha, S.; Chauhan, S. S. “Antimalarial Evaluation of Copper(II) Nanohybrid Solids: Inhibition of Plasmepsin II,A Hemoglobin-degrading Malarial Aspartic Protease from Plasmodium falciparum “ J. Biol. Inorg. Chem. 2010, 15, 373-385 (IF, 3.358; Springer; ISSN, 1432-1327).

 

  *Corresponding Author

  • “1st International conference on Integrative Chemistry, Biology and Translational Medicine (ICBTM-2019)” Feb 25-26, 2019, Jointly organised by Centre for Global Health, Hansraj College University of Delhi, Delhi, India & Loyola University Stritch School of Medicine Maywood, Chicago USA. Role:Convener
  • Indo-US Colloquium on Recent developments in interdisciplinary research, July 2, 2018, Jointly organised by IQAC, Department of Chemistry, Hansraj College University of Delhi, Delhi, India & Loyola University Stritch School of Medicine Maywood, IL USA. Role: Convener
  • “Indo-Portuguese workshop on Nanotechnology in Chemistry and Biology (INCB- 2016)” jointly organized by Department of Chemistry, Hansraj College and CQM, University of Madeira, Portugal (February 12-13, 2016). Role: National Coordinator.
  • India International Science Festival (IISF-2015) organized by Ministry of Science & Technology, Govt. of India during December 4-8, 2015 (Role: Coordinator).
  • MHRD funded “National Workshop on Role of Technical Terminology in Higher Education” (23-24 July, 2015) in Hansraj College, University of Delhi (Role: Coordinator).
  • “1st International conference on emerging trends of nanotechnology in drug discovery” was organized (May 26-27, 2014) by Sri Venkateswara College & Department of Biochemistry, University of Delhi South Campus in association with Centro de Química da Madeira, Universidade da Madeira, Portugal (Role: National coordinator and organizing secretary).
  • “A National Symposium on Recent Trends in Innovative Research at Under- graduation: Science and Society” was organized (28th Feb-2nd March 2013) by Sri Venkateswara College, University of Delhi (Role: Organizing secretary).
  • A national seminar on Recent Trends in Chemistry” was organized (March 20-22, 2012) by Department of Chemistry, Sri Venkateswara College, University of Delhi (Role: Treasurer).
  • A national conference on “Convergence of Science and Spirituality” was organized (5- 6th Nov 2011) by Sri Venkateswara College in association with Institute for Science and Spirituality, A Study Wing of ISKCON Delhi (Role: Coordinator).
  • “Computer Aided Drug Design”, National Workshop on Bioinformatics: Resources, Tools, and its applications (19-27 July 2021), Zakir Husain Delhi College, University of Delhi, New Delhi.
  • “Discovery of next-generation antimalarials” Amity University Noida, Friday, 11 June 2021.
  • “Understanding the therapeutic developments for novel coronavirus COVID-19 management” DiSTAP (Singapore-MIT Alliance for Research and Technology (SMART) Centre) Biweekly seminar, Thursday, 23rd April 2020.
  • “Design of multistage inhibitors of malaria parasite; malarial aspartic proteases as crucial drug targets to achieve multistage activity” VI Forum PPGDITM (UFRPE-UFPB-UFRN-UFC), Recife, capital of Pernambuco State, in the campus of the Federal Rural University of Pernambuco, Brazil, 28th November's 2019.
  • “Multistage Antimalarials Targeting Malarial Proteases” during International Workshop on Chemistry and Chemical Biology of Carbohydrates, Nucleic Acids and Antibiotics (22- 24, May 2019) organized by University of Debrecen, Hungary.
  • “New Antimalarials: Multistage Inhibitors of Malaria Parasite as Emerging Hope for the Malaria Eradication” Department of Pharmaceutical Chemistry, University of Debrecen, Hungary (June 12,2018).
  • Invited Speaker for the workshop “How to get published research paper in the right journals” organized by Grace India Educational Charitable Trust, Delhi at Hansraj College, University of Delhi (October 27, 2018).
  • "Discovery of Multistage Antimalarials: Synergistic Fusion of Privileged Bioactive Scaffolds Triggers Growth Inhibition of Malaria Parasite Plasmodium Falciparum" Drug Discovery & Therapy World Congress (DDTWC-2017) July 10-13, 2017, Boston, MA United States of America.
  • "Functionalized Small Molecules As Potential Antimalarial Agents" National conference on Frontiers in Research & Development on Agriculture, Bio-medicinal, Chemical and Pharmaceutical sciences (4th March, 2016), Mewar University, Rajasthan.
  • ‘Functionalized Phthalimides Enriched with Technological Applications’ International Conference on Recent Advances in Chemical Sciences (ICRACS 2013), Department of Chemistry, Arya P.G. College, Panipat, Haryana (24-26 February, 2013).
  • VI Forum PPGDITM (UFRPE-UFPB-UFRN-UFC), Recife, capital of Pernambuco State, in the campus of the Federal Rural University of Pernambuco, Brazil, 28-29th November's 2019.
  • Indo-US Colloquium on Recent developments in interdisciplinary research, July 2, 2018, Jointly Organised by IQAC, Department of Chemistry, Hansraj College University of Delhi, Delhi, India & Loyola University Stritch School of Medicine Maywood, IL USA
  • ACS On Campus February 5, 2018, University of Delhi, Delhi-110007
  • Indo-Hungarian Symposium on Recent Advances in Chemistry and Biology, December, 11, 2017; Organized by Department of Chemistry, Miranda House, University of Delhi, Delhi, India in association with Department of Pharmaceutical Chemistry, University of Debrecen, Debrecen,Hungary
  • Drug Discovery & Therapy World Congress (DDTWC-2017) July 10-13, 2017, Boston, MA United States of America.
  • 16th Annual Cancer Research Symposium “Convergence of Science and Engineering in Cancer” Koch Institute, MIT, Cambridge, MA USA (June 16, 2017).
  • 2016 MIT Digital Health Conference (September 7-8, 2016) organized by Massachusetts Institute of Technology, USA.
  • Indo-Portuguese workshop on Nanotechnology in Chemistry and Biology (INCB- 2016)” jointly organized by Department of Chemistry, Hansraj College and CQM, University of Madeira, Portugal (February 12-13, 2016).
  • MHRD funded National Workshop on “Role of Technical Terminology in Higher Education” (23-24 July, 2015) in Hansraj College (University of Delhi).
  • 7th edition of Nanoschool, from 6th to 9th October 2014, Centro de Química da Madeira, Universidade da Madeira, Campus da, Penteada, 9020-105 Funchal, PORTUGAL.
  • Brijesh Rathi* “Phthalimides as potential antimalarial agents embodying cyclic amine scaffolds” International Conference on Chemical Biology (ICCB-2014), CSIR-Indian Institute of Chemical Technology, Hyderabad (AP) INDIA (February 6-8, 2014).
  • 1st International conference on emerging trends of nanotechnology in drug discovery (INCB-2016) organized by Sri Venkateswara College and CQM, University of Madeira, Portugal (May 26-17, 2014).
  • International Conference on Recent Advances in Chemical Sciences (ICRACS2013), Department of Chemistry, Arya P.G. College, Panipat, Haryana (24-26 February, 2013).

Patents (Indian) Filed.

  • Brijesh Rathi, Prakasha Kempaiah, Agam P Singh, Snigdha Singh, Yash Gupta, Neha Sharma, Poonam, Ravi Durvasula, “Hydroxyethylamine-based Piperazine Compounds, and Methods of Producing and Using the Same for Treating Disease” (Patent filed; Application No. 202011056923; 29 Dec 2020).
  • Neha Sharma, Brijesh Rathi, Agam P Singh “Novel Antiparasitic Agents Based on Piperazine and Uses thereof” (Patent Filed; Application No. 202011043767; 08 October 2020).
  • RP Singh, Kavita, R. Rangarajan, Brijesh Rathi, Rishi Pal Singh “Chalcone Derivatives and Uses thereof” (Patent filed; Application No. 2017110041295).
  • Dhruv Kumar and Brijesh Rathi ‘Anti-viral herbal inhaler having nano-gold based herbal formulation” (Provisional Patent Filed; Application No. 202011018564; 30 April 2020).

Patent (International) -Filed.

  • Brijesh Rathi, Snigdha Singh, Neha Sharma, Poonam, Agam P Singh, Ravi Durvasula, Prakasha Kempaiah “Piperazine Compounds, and Methods of Producing and Using the Same for Treating Disease” (US Patent App. 17347720, 15 June 2021).
  • Steven Bradfute, Brijesh Rathi, Yash Gupta, Poonam, Ravi Durvasula, Prakasha Kempaiah “Calxinin Compositions and Method for Treating Viral Infections” (US provisional Patent App. 63/016,741; 28th April 2020).
  • Zoltner Martin, Zahedifard Farnaz, Brijesh Rathi, Neha Sharma, Meenakshi Bansal Phthalimide-based substances with antiprotozoal activity and their use in therapy” (Czech patent application number, PV 2021-408; 03 September 2021).

Awards/Fellowships Availed

  • 2019 – CAPES-Print Fellowship from Coordenação de Aperfeiçoamento de Pessoal de Nível Superior, Ministry of Education,Brazil.
  • The prestigious “Excellence Awards for In Service Teachers” (2018) by University of Delhi. This award is given to highly deserving individuals for their contribution to academicactivities.
  • “Best Young Teacher award” by Grace India Award-2018 Function on the occasion of 87th Birth Anniversary of Bharat Ratna Dr. APJ Abdul Kalam at Hansraj College University of Delhi.
  • UGC-Raman International Fellowship (2016-2017) by UGC, Ministry of Human Recourses and Development, Govt. ofIndia.
  • Early Carrier Research Award (2016-2019) by Science & Engineering Research Board (SERB), Ministry of Science of Technology, Govt. ofIndia.
  • Young Scientist Fellowship (2011-2014) by DST, Ministry of Science of Technology, Govt. of India.
  • Ambassador for Bentham Science Publishers(2018).

Honorary Positions (Editing/Review/Membership of Scientific Bodies):

  • Section Editor, Current Topics in Medicinal Chemistry (IF: 3.37), Bentham Science Publishers.
  • Associate Editor, Chemical Biology Letters, Indian Science Publishers
  • Life Member (L32926), The Indian Science Congress Association, Kolkata, India
  • Executive Guest Editor, special issue on “Self-assembled nanostructures in medicinal chemistry: Advances and applications” of Current Topics in Medicinal Chemistry (IF: 2.90).
  • Editorial Review Board Member, ARKIVOC, Arkat USA.
  • Editorial Member, "Journal of Nano Education" Published by American Scientific Publishers, USA.
  • Editorial Member, American Journal of Applied Chemistry” Published by Science Publishing Group, New York, USA.
  • Editorial Member, “American Journal of Nanoscience and Nanotechnology” Published by Science Publishing Group, New York, USA.
  • Editorial         Member,   “Chemical   Biology   Letters”    Published    by    Indian   Science Publications.
  • Reviewer, Journal of Medicinal Chemistry, Biochemistry; Plos ONE, Chemical Science, RSC Advances; Physical Chemistry Chemical Physics; Microbial Pathogenesis; Journal of Heterocyclic Chemistry; Bioorganic Medicinal Chemistry; ARKIVOC etc.
  • Jury Member, DST Inspire 2015.

Short Course(s) 

  • Four Credit Course on “Antimalarial Drug Discovery Towards Malaria Eradication” Federal Rural University of Pernambuco, Recife, Brazil, 27 November 2019.
  • Antimalarial drugs: Preclinical and Clinical Aspects (14 credit PhD elective course and undergarduate elective course) 7-16 October 2019, University of Debrecen, Hungary.

Gallery